Introduction:
The Biopsy Devices Market continues to grow steadily, driven by increasing demand for early disease diagnosis and advancements in medical technology. Biopsy devices, including needles, forceps, and guns, are essential tools for obtaining tissue samples for diagnostic purposes. As healthcare providers prioritize early detection and personalized medicine, the biopsy devices market is expected to see sustained growth. Factors such as a rising aging population and the prevalence of cancer contribute to the market’s expansion. Additionally, ongoing research and development efforts are likely to introduce innovative biopsy devices, further propelling market growth.
Sample link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2809
Key highlights:
- On 16 March 2021, IZI Medical Products, LLC leading manufacturer of medical devices for radiology and oncology procedures, launched fully automated Quick-Core Auto Biopsy System for soft tissue biopsy. The Quick-Core Auto is a fully automatic biopsy device and lightweight, that builds upon the legacy of IZI’s Quick-Core semi-automatic biopsy system, and offers the same reliability, precision, and quality.
- Hologic announced enhancement in Brevera with CorLumina Imaging Technology in August 2020. Which integrates vacuum-assisted tissue acquisition, real-time imaging verification, and advanced post-biopsy handling, the innovation will fuel the customer base of the firm.
- On 24 February 2021, Twist Bioscience Launched Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studies. Company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and a robust, end-to-end sample preparation and target enrichment solution for identifying methylated regions in the human genome.
Analyst View:
The market for biopsy instruments has a bright future, according to analysts. Today’s healthcare system cannot function without biopsy machines because of the growing emphasis on early disease identification, especially in cases like cancer. The aging population and the increasing prevalence of disorders that require tissue sampling for an appropriate diagnosis and treatment planning are two factors driving the growth of this market.PDF report:
https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/2809
Segmentation:
The Biopsy Devices market can be segmented into several categories:
- By Device Type (Breast biopsy devices, Gastrointestinal (GI) biopsy devices, Soft tissue biopsy devices, Bronchial biopsy devices, Gynecological biopsy devices, Robotic biopsy devices, and Other devices), By Imaging Technology (CT scan, Stereotactic-guided biopsy, Ultrasound-guided biopsy, MRI-guided biopsy, and Others)
- By Application (Breast biopsy, Gastrointestinal (GI) biopsy, Prostate, Liver, Lung, Kidney, Gynecological, and Others)
- By End-User (Diagnostics and Hospitals)
- By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
Key trends shaping the Biopsy Devices market include:
- Minimally Invasive Techniques: There is a growing preference for minimally invasive biopsy techniques, such as core needle biopsies and endoscopic biopsies. These methods offer reduced patient discomfort, quicker recovery times, and lower healthcare costs, driving their adoption.
- Precision Medicine: The rise of precision medicine is driving the demand for more specialized biopsy devices. As treatments become increasingly personalized, there is a need for biopsy tools that can provide highly specific tissue samples for molecular analysis.
- Automation and Robotics: Automation and robotics are making their way into biopsy procedures, enabling greater precision and reducing the risk of human error. Automated biopsy devices are becoming more common in the market.
- Liquid Biopsies: Liquid biopsies, which involve analyzing blood or other bodily fluids for biomarkers, are gaining popularity. These non-invasive biopsy methods are particularly valuable for monitoring cancer progression and treatment response.
Competitive Landscape & their strategies of Biopsy Devices Market:
The prominent players operating in the Biopsy Devices Market includes
- Bard Inc.
- Leica Biosystems
- Dickinson and Company
- Ethicon EndoSurgery Inc.
- Fujifilm Medical Systems
- Veran Medical Technologies
- Boston Scientific Corporation
- MDxHealth
- Medtronic
- Argon Medical Devices Inc.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
About Us:
Prophecy Market Insights is a leading provider of market research services, offering insightful and actionable reports to clients across various industries. With a team of experienced analysts and researchers, Prophecy Market Insights provides accurate and reliable market intelligence, helping businesses make informed decisions and stay ahead of the competition. The company’s research reports cover a wide range of topics, including industry trends, market size, growth opportunities, competitive landscape, and more. Prophecy Market Insights is committed to delivering high-quality research services that help clients achieve their strategic goals and objectives.
To know more
Contact Us:
Sales
Prophecy Market Insights
📞 US toll free: +1 860 531 2574
📞 Rest of world: + 91 7775049802
✉ Email– sales@prophecymarketinsights.com
🌐 Website- www.prophecymarketinsights.com
Follow us on: